Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study

키워드

참고문헌 (38)

1. "The top 10 causes of death" (2015)[URL]
2. Vestbo J, "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary", Am J Respir Crit Care Med, 187, pp.347~365 (2013)
3. Franciosi LG, "Markers of disease severity in chronic obstructive pulmonary disease", Pulm Pharmacol Ther, 19, pp.189~199 (2006)
4. Franciosi LG, "Markers of exacerbation severity in chronic obstructive pulmonary disease", Respir Res, 7, pp.74~ (2006)
5. Barnes PJ, "Pulmonary biomarkers in chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 174, pp.6~14 (2006)
6. Sinden NJ, "Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence", Thorax, 65, pp.930~936 (2010)
7. Walter RE, "Systemic inflammation and COPD: the Framingham Heart Study", Chest, 133, pp.19~25 (2008)
8. Vestbo J, "Systemic inflammation and progression of COPD", Thorax, 62, pp.469~470 (2007)
9. Williams KA, "Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer", Gynecol Oncol, 132, pp.542~550 (2014)
10. Roxburgh CS, "Role of systemic inflammatory response in predicting survival in patients with primary operable cancer", Future Oncol, 6, pp.149~163 (2010)
11. Kacan T, "Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers?", Asian Pac J Cancer Prev, 15, pp.2089~2094 (2014)
12. Walsh SR, "Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer", J Surg Oncol, 91, pp.181~184 (2005)
13. Azab B, "Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients", Ann Surg Oncol, 19, pp.217~224 (2012)
14. Stotz M, "Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer", Br J Cancer, 109, pp.416~421 (2013)
15. Guasti L, "Neutrophils and clinical outcomes in patients with acute coronary syndromes and", or cardiac revascularisation: a systematic review on more than 34,000 subjects, 2011, pp.106, 591~599
16. Bhat T, "Neutrophil to lymphocyte ratio and cardiovascular diseases: a review", Expert Rev Cardiovasc Ther, 11, pp.55~59 (2013)
17. MacNee W, "Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease", Ann Med, 45, pp.291~300 (2013)
18. Agustí AG, "Systemic effects of chronic obstructive pulmonary disease", Eur Respir J, 21, pp.347~360 (2003)
19. Gan WQ, "Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis", Thorax, 59, pp.574~580 (2004)
20. Agusti AG, "COPD, a multicomponent disease: implications for management", Respir Med, 99, pp.670~682 (2005)
21. Berger JS, "Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention", Am J Cardiol, 94, pp.649~651 (2004)
22. Curkendall SM, "Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients", Ann Epidemiol, 16, pp.63~70 (2006)
23. Mannino DM, "Low lung function and incident lung cancer in the United States:data from the first National Health and Nutrition Examination Survey follow-up", Arch Intern Med, 163, pp.1475~1480 (2003)
24. Schols AM, "Pulmonary cachexia", Int J Cardiol, 85, pp.101~110 (2002)
25. Biskobing DM, "COPD and osteoporosis", Chest, 121, pp.609~620 (2002)
26. Yao Y, "Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung", Cancer Immunol Immunother, 62, pp.471~479 (2013)
27. Yilmaz H, "Neutrophil-lymphocyte ratio may be superior to C-reactive protein for predicting the occurrence of postmenopausal osteoporosis", Endocr Regul, 48, pp.25~33 (2014)
28. Kang MH, "The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer", Br J Cancer, 111, pp.452~460 (2014)
29. Hurst JR, "Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 174, pp.867~874 (2006)
30. Celli BR, "The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease", N Engl J Med, 350, pp.1005~1012 (2004)
31. Marin JM, "Prediction of risk of COPD exacerbations by the BODE index", Respir Med, 103, pp.373~378 (2009)
32. Pinto-Plata V, "Profiling serum biomarkers in patients with COPD: associations with clinical parameters", Thorax, 62, pp.595~601 (2007)
33. Liu SF, "Correlation between serum biomarkers and BODE index in patients with stable COPD", Respirology, 14, pp.999~1004 (2009)
34. Gaki E, "Associations between BODE index and systemic inflammatory biomarkers in COPD", COPD, 8, pp.408~413 (2011)
35. Hallin R, "Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD)", Respir Med, 100, pp.561~567 (2006)
36. Pouw EM, "Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss", Clin Nutr, 19, pp.95~99 (2000)
37. Bahadori K, "Risk factors of hospitalization and readmission of patients with COPD exacerbation:systematic review", Int J Chron Obstruct Pulmon Dis, 2, pp.241~251 (2007)
38. inganayagam A, "Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease", Ann Am Thorac Soc, 10, pp.81~89 (2013)

관련 논문AI추천